Kforce Insider Filing: 336-Share Purchase and 10,061 RSU Grant for Director
Rhea-AI Filing Summary
Form 4 summary (Kforce Inc., KFRC)
This Form 4, filed 08/07/2025, reports insider activity for director Derrick D. Brooks with an earliest transaction date of 08/06/2025.
- Share purchase: 336 common shares acquired at $32.71, resulting in 2,111 shares beneficially owned (direct).
- Equity grant: 10,061 Restricted Stock Units (RSUs) granted; each RSU represents a contingent right to one share.
- Vesting and rights: RSUs vest one year from grant subject to continued service; dividend equivalent rights accrue as dividends are paid.
Form was signed by Susan A. Gager, Attorney-in-Fact for Derrick D. Brooks on 08/07/2025.
Positive
- Director purchase disclosed: 336 shares acquired at $32.71 on 08/06/2025
- Equity alignment via RSUs: Grant of 10,061 Restricted Stock Units with one-year vesting and dividend equivalent rights
Negative
- None.
Insights
TL;DR: Director Derrick D. Brooks purchased 336 shares and received 10,061 RSUs; disclosed 08/06/2025, filed 08/07/2025.
The filing shows a direct open-market purchase of 336 shares at $32.71 and a contemporaneous grant of 10,061 RSUs. The post-transaction direct holdings are reported as 2,111 shares and 10,061 RSUs remain outstanding as contingent equity. All RSUs vest one year from grant subject to continued service, and dividend equivalent rights accrue as dividends are paid. This is a routine compensation and purchase disclosure; no financial results, guidance, or material corporate events are reported.
TL;DR: Routine director compensation and purchase disclosure; vesting tied to continued service and standard dividend equivalents.
The document documents an equity grant under the issuer's stock incentive plan and an insider purchase by a director. The RSUs are explicitly described as contingent rights to receive common stock and vest one year from grant subject to continued service. The filing is signed by an attorney-in-fact on 08/07/2025. From a governance perspective, the filing provides the required transparency on director compensation and holdings but does not disclose amendments to governance policies or extraordinary transactions.